Article

Medication and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia

2024-11-20

Abstract excerpt

<h4>Background</h4> People with schizophrenia differ in the type and severity of symptoms experienced, as well as their response to medication. A better understanding of the factors that influence this heterogeneity is necessary for the development of individualised patient care. Here, we sought to investigate the relationships between phenotypic severity and both medication and pharmacogenomic variables in a cros...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3791abb4-8b8d-5324-96ea-a0e9be8df6b3
DOI: 10.1101/2024.11.20.24317526

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Medication and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophreniaDOI 10.1101/2024.11.20.24317526Read

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorderSemantic proximity Read

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersSemantic proximity Read

GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA.Semantic proximity Read

Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene StudySemantic proximity Read

Machine learning for novel phenotyping in schizophrenia.Semantic proximity Read

Pharmacogenomics of antipsychotics efficacy for schizophreniaSemantic proximity Read

Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia.Semantic proximity Read

Common Substrates of Early Illness Severity: Clinical, Genetic, and Brain EvidenceSemantic proximity Read

Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in a case-control study of severe mental illness in the Paisa populationSemantic proximity Read

Assessing the validity of a self-reported clinical diagnosis of schizophreniaSemantic proximity Read

Fundamental Role of Methylenetetrahydrofolate Reductase 677 C → T Genotype and Flavin Compounds in Biochemical Phenotypes for Schizophrenia and Schizoaffective PsychosisSemantic proximity Read

Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning StudySemantic proximity Read